Schrodinger

Schrodinger ROCE

The Return on Capital Employed (ROCE) of Schrodinger (SDGR) as of Nov 10, 2026 is -45.84 %. In the previous year, Return on Capital Employed (ROCE) was -49.66 % — a change of -7.69% (higher).

ROCE

-45.84 %

YoY

-7.69%

Last updated:

In 2025, Schrodinger's return on capital employed (ROCE) was -45.84 %, a -7.69% increase from the -49.66 % ROCE in the previous year.

The Schrodinger ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
39.08 USD
Jan 1, 2019
41.48 USD
Jan 1, 2020
-9.76 USD
Jan 1, 2021
-20.00 USD
Jan 1, 2022
-32.78 USD
Jan 1, 2023
-32.35 USD
Jan 1, 2024
-49.66 USD
Jan 1, 2025
-45.84 USD
The Schrodinger ROCE history
YEARROCEYoY
-45.84 %-7.69%
-49.66 %+53.52%
-32.35 %-1.31%
-32.78 %+63.85%
-20.00 %+104.93%
-9.76 %-123.53%
41.48 %+6.14%
39.08 %-6.79%
41.93 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Schrodinger Stock analysis

What does Schrodinger do? Schrodinger Inc is a leading company in the field of computational molecular dynamics and computer-aided drug design. The company was founded in 1990 by Erich Schneider and Richard Friesner in New York City. In its early years, the company focused on creating simulations of chemical reactions and understanding how molecules interact. Since then, Schrodinger Inc has expanded its products and services. One of their important services is computer-aided drug design. The company has developed a successful strategy to accelerate and optimize drug development programs for biopharmaceutical companies and academic institutions. The business model of Schrodinger Inc is based on providing software tools for scientists, industry companies, and academic institutions. The company specializes in developing software for molecular modeling and calculating properties of molecules, such as predicting accuracy in ligand binding to proteins. Their products enable researchers to perform simulations and analyze data for better prediction of molecular structure and interactions with other molecules. Schrodinger Inc also offers a wide range of products specialized in drug development. These include tools for calculating molecular properties of compounds, such as lipophilicity, polarity, and hydrogen bonding. The software tools also provide options for exchanging interactive conformations of molecules and identifying unique molecular properties to enhance binding to target proteins. Another product offering from Schrodinger Inc is the so-called "Discovery Units" - specialized units that focus on specific applications and therapeutic areas. These Discovery Units can encompass biopharmaceuticals, drugs for specific diseases, or groups of diseases. Through these units, customers can access specialized software products and personalized services. Overall, Schrodinger Inc is a pioneer company in the computer simulation of molecules and computer-aided drug design. For the future, Schrodinger Inc plans to expand its offering of personalized services and utilize AI technologies to enhance models and algorithms for drug discovery. Schrodinger is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Schrodinger's Return on Capital Employed (ROCE)

Schrodinger's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Schrodinger's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Schrodinger's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Schrodinger’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Schrodinger stock

Return on Capital Employed (ROCE) of Schrodinger is -45.84 % in 2025.

Return on Capital Employed (ROCE) of Schrodinger changed from -49.66 % to -45.84 %, representing a -7.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Schrodinger since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Schrodinger with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Schrodinger

All Key Metrics — Schrodinger